Successful immunization of an allogeneic bone marrow transplant recipient with live, attenuated yellow fever vaccine

Journal of Travel Medicine

Volumn 16, Issue 5, 2009, Pages 365-367

  Yax, Justin A ^a   Farnon, Eileen C ^b,c   Engleberg, N Cary ^a,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA VACCINE; HEPATITIS A HEPATITIS B VACCINE; INFLUENZA VACCINE; YELLOW FEVER VACCINE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DIPHTHERIA; GRAFT VERSUS HOST REACTION; HEPATITIS A; HEPATITIS B; HUMAN; HUMAN TISSUE; IMMUNIZATION; INFLUENZA; MALE; XEROPHTHALMIA; YELLOW FEVER;

BONE MARROW TRANSPLANTATION; ECUADOR; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; TRANSPLANTATION, HOMOLOGOUS; YELLOW FEVER; YELLOW FEVER VACCINE;

EID: 70349260295     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2009.00336.x     Document Type: Article

References (15)

1. Centers for Disease Control and Prevention. Health information for international travel 2008. Atlanta : US Department of Health and Human Services, Public Health Service, 2007.
2. Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR Morb Mortal Wkly Rep 2000 49 (RR-10 99.
3. Committee to Advise on Tropical Medicine and Travel (CATMAT). The immunocompromised traveler. Can Commun Dis Rep 2007 33 (ACS-4 1 24.
4. Ljungman P, Engelhard D, de la Camara R, et al. for the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 2005 35 : 737 746.
5. Singhal S, Mehta J. Reimmunization after blood or marrow stem cell transplantation. Bone Marrow Transplant 1999 23 : 637 646.
6. Kotton CN, Ryan ET, Fishman JA. Prevention of infection in adult traveler after solid organ transplantation. Am J Transplant 2005 5 : 8 14.
7. Gowda R, Cartwright K, Bremner JAG, et al. Yellow fever vaccine: a successful vaccination of an immunocompromised patient. Eur J Haematol 2004 72 : 299 301.
8. Receveur MC, Thiebaut R, Vedy S, et al. Yellow fever vaccination of human immunodeficiency virus infected patients: report of two cases. Clin Infect Dis 2000 31 : e7 e8.
9. Kengsakul K, Sathirapongsasuti K, Punyagupta S. Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection. J Med Assoc Thai 2002 85 : 131 134.
10. Monath TP. Yellow fever vaccine. In: Plotkin S, Orenstien W, eds. Vaccines. 4th ed. Phila : WB Saunders, 2003 1095 176.
11. Barwick RE. History of thymoma and yellow fever vaccination. Lancet 2004 364 : 936.
12. Vasconcelos PFC, Luna EJ, Galler R, et al. Brazilian Yellow Fever Vaccine Evaluation Group. Serious adverse events associated with yellow fever 17D vaccine in Brazil: report of two cases. Lancet 2001 358 : 91 97.
13. Martins RM, Galler R, Freire MS, et al. Letter to the editor: yellow fever vaccination: some thoughts on how much is enough. Vaccine 2007 25 : 10 11.
14. Massad E, Coutinho FAB, Burattini MN, et al. Yellow fever vaccination: how much is enough? Vaccine 2005 23 : 3908 3914.
15. Khromava AY, Eidex RB, Weld LH, et al. Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events. Vaccine 2005 23 : 3256 3263.